Clinical Trials Directory

Trials / Unknown

UnknownNCT00189683

Xeloda Vs Monitoring in Advanced Colorectal Cancer Responsive to Chemotherapy

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
Sponsor
Association Européenne de Recherche en Oncologie · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To compare maintenance chemotherapy with Xeloda to control after best response with first line chemotherapy in advanced colorectal cancer. Main endpoint is progression free survival. A total of 300 patients will be included.

Conditions

Interventions

TypeNameDescription
PROCEDUREMonitoring
PROCEDUREXeloda

Timeline

First posted
2005-09-19
Last updated
2005-09-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00189683. Inclusion in this directory is not an endorsement.